Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02443766
Other study ID # 11G.488
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 5, 2012
Est. completion date March 2, 2017

Study information

Verified date July 2022
Source Thomas Jefferson University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Over 2 decades scientists have been studying the effect on brain function from meditation practices. The purpose of this study is to measure the effect of a meditation retreat program on serotonin and dopamine transporter binding and changes in cerebral blood flow. The retreat program that will be followed is a week-long retreat called the Ignatian Retreat.


Description:

This study will utilize DaTscan single photon emission computed tomography (SPECT) and functional magnetic resonance imaging (fMRI) in healthy subjects within one month of entering the retreat. The study uses DaTscan to measure the effect on serotonin and dopamine transporter binding, and functional magnetic resonance imaging (fMRI) to measure the effect on cerebral blood flow. The Ignatian Retreat is a weeklong retreat which involves meditation and prayer. Additionally, study participants will complete a variety of questionnaires and scales to measure psychological and spirituality states. The scans and questionnaires will be completed before and after the participant has completed the retreat. The ultimate goal of the study is to analyze and compare pre and post imaging and neuropsychological and spirituality changes in healthy controls who participate in this retreat.


Recruitment information / eligibility

Status Completed
Enrollment 14
Est. completion date March 2, 2017
Est. primary completion date March 2, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Able to give informed consent and willing to complete the study. - Willing to undergo the full imaging procedures. - Women of childbearing potential with a negative serum pregnancy test. Exclusion Criteria: - Any neurological or psychiatric disorders, including drug or alcohol abuse, that may interfere with cerebral blood flow as determined by the principal investigator. - Any medical conditions that may interfere with cerebral blood flow as determined by the principal investigator. - Currently taking medication that might affect cerebral blood flow (i.e. antidepressants, antipsychotics, anxiolytics, benzodiazepines, sedatives, antiseizure medications) - Subject is unable or unwilling to lie still in the scanner (i.e. due to claustrophobia or weight > 350 pounds) - Subject has metal in their body or other reason that they cannot undergo magnetic resonance imaging. - Previous brain surgery or intracranial abnormalities they may complicate interpretation of the brain scans. (e.g. stroke, tumor, vascular abnormality). - Pregnancy - Allergy to iodine or shellfish. - Concurrent participation in another research protocol that might affect the outcome of this study as determined by the principle Investigator.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Meditation Retreat
Weeklong retreat which includes meditation and prayer.

Locations

Country Name City State
United States Thomas Jefferson University Philadelphia Pennsylvania

Sponsors (1)

Lead Sponsor Collaborator
Thomas Jefferson University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Speilberger State Trait Anxiety Inventory (STAI) This validated questionnaire will be used as one of the evaluation questionnaires for the study. The Speilberger State Trait Anxiety Inventory (STAI) contains a total of 40 questions, half of which relate to the way subjects are feeling at the moment and half of which ask them to describe how they usually feel. Within one month of the retreat
Other Profile of Moods Scale (POMS) The Profile of Mood States (POMS) is a validated questionnaire of 65 single word items that asks "How have you been feeling in the past week including today." The subjects will select their response to each word that describes a mood or feeling on a Likert scale from 1= Not at All, 2= A Little, 3=Moderately, 4=Quite a lot, to 5=Extremely. The responses are scored to generate values for Tension, Anger, Confusion, Depression and Vigor. The higher scores indicate a greater presence of that mood or state. Within one month of the retreat
Other Beck Depression Inventory (Beck 1972) This validated questionnaire will be used as one of the evaluation questionnaires for the study. The Beck Depression Inventory (Beck 1972) is a standard 21 item questionnaire probing cognitive and somatic symptoms of depression. The higher scores indicate a greater presence of depression. Within one month of the retreat
Other Standard Form-12 (SF-12) This 12-item validated questionnaire will be used as one of the evaluation questionnaires for the study. The subjects will select their response to each word that describes a mood or feeling on a Likert scale. Within one month of the retreat
Other Hood Mysticism Scale (Lifetime) This validated scale will be used as one of the evaluation questionnaires for the study. Items are rated on a five-point scale with negatively worded items reverse scored. The responses are scored to generate values for Extrovertive Mysticism, Religious Interpretation, and Introvertive Mysticism. Within one month of the retreat
Other Brief Multidimensional Measure of Religiousness/Spirituality This 30-item validated questionnaire will be used as one of the evaluation questionnaires for the study. The responses are scored to generate values for Suffering, Positing Sharing, Crying, Emotional Attention, Feel for Others, and Emotional Contagion. Within one month of the retreat
Other Gratitude Questionnaire This validated questionnaire will be used as one of the evaluation questionnaires for the study. The subjects will select their response on a Likert scale. The higher scores indicate a greater sense of gratitude. Within one month of the retreat
Other Daily Spiritual Experience Scale This validated questionnaire will be used as one of the evaluation questionnaires for the study. This assessment measures ordinary, or daily, spiritual experiences. Within one month of the retreat
Other The Assessment of Spirituality and Religious Sentiments (ASPIRES ) This validated questionnaire will be used as one of the evaluation questionnaires for the study. This assessment measures Religious sentiments and Spiritual Transcendence. Within one month of the retreat
Other Index of Core Spiritual Experiences (INSPIRIT) This validated questionnaire will be used as one of the evaluation questionnaires for the study to evaluate the presence or frequency of certain religions. Within one month of the retreat
Other Functional Assessment of Chronic Illness Therapy Spiritual Well-Being (FACIT-Sp-12) This validated questionnaire will be used as one of the evaluation questionnaires for the study. The 12-item assessment is used to measure spiritual well-being by asking patients to describe aspects of spirituality and/or religious faith that contribute to health related quality of life. Within one month of the retreat
Other Cloninger Self-Transcendence Scale This validated questionnaire will be used as one of the evaluation questionnaires for the study. The subjects will select their response on a Likert scale. The higher scores indicate a greater presence to self-transcendence and well being. Within one month of the retreat
Other Five Facet Mindfulness Questionnaire This validated questionnaire will be used as one of the evaluation questionnaires for the study.The analysis yielded five factors that appear to represent elements of mindfulness as it is currently conceptualized.The five facets are observing, describing, acting with awareness, non-judging of inner experience, and non-reactivity to inner experience. Within one month of the retreat
Primary Single Photon Emission Computed Tomography (SPECT) Imaging (DaTScan) To detect changes in dopamine and serotonin before and after a meditation retreat program in serotonin transporter and dopamine transporter binding. Within one month of the retreat
Secondary functional MRI To detect changes in cerebral blood flow before and after a meditation retreat program. Within one month of the retreat
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1

External Links